Clinical Evaluation of Imipenem/Cilastatin Sodium as a second Line regimen in Severe Infections Associated with Hematologic Disorders

Shoichiro Tsuda, Hiroyuki Nakai, Tsuyoshi Murakami, Suguru Seryu, Teruyuki Takashima, Shinji Tanaka, Hitoshi Nakagawa, Hikari Nishigaki, Tsukasa Okuda, Kazuhiro Nishida, Shohei Yokota, Masafumi Taniwaki, Shinichi Misawa, Eei Kashima, Hiromi Yashige, Yuko Kuzuyama, Hiroshi Fujii, Tetsuro Nakai, Yasuo Ohkawara, Hitoshi ImanishiShigeo Horiike

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)886-898
Number of pages13
JournalThe Japanese Journal of Antibiotics
Volume44
Issue number8
DOIs
StatePublished - Dec 1991

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Clinical Evaluation of Imipenem/Cilastatin Sodium as a second Line regimen in Severe Infections Associated with Hematologic Disorders'. Together they form a unique fingerprint.

  • Cite this

    Tsuda, S., Nakai, H., Murakami, T., Seryu, S., Takashima, T., Tanaka, S., Nakagawa, H., Nishigaki, H., Okuda, T., Nishida, K., Yokota, S., Taniwaki, M., Misawa, S., Kashima, E., Yashige, H., Kuzuyama, Y., Fujii, H., Nakai, T., Ohkawara, Y., ... Horiike, S. (1991). Clinical Evaluation of Imipenem/Cilastatin Sodium as a second Line regimen in Severe Infections Associated with Hematologic Disorders. The Japanese Journal of Antibiotics, 44(8), 886-898. https://doi.org/10.11553/antibiotics1968b.44.886